Literature DB >> 19486360

Early onset myoclonic epilepsy and 15q26 microdeletion: observation of the first case.

Chiara Veredice1, Flaviana Bianco, Ilaria Contaldo, Daniela Orteschi, Maria Chiara Stefanini, Domenica Battaglia, Donatella Lettori, Francesco Guzzetta, Marcella Zollino.   

Abstract

The authors report the study of a 30-month-old girl with refractory myoclonic epilepsy associated with mental retardation, growth delay, peculiar facial appearance, and minor physical anomalies. Extensive genetic studies were performed, including an array-based comparative genomic hybridization (array-CGH) that showed a cryptic interstitial deletion of 15q (5 Mb) affecting the 15q26.1-26.2 region. Partial deletions of the long arm of chromosome 15, including the 15q26 region, were observed in syndromic associations that typically include congenital diaphragmatic hernia, but neurologic features were poorly described and epileptic seizures were never reported. Our findings suggest that genes for seizures could be included in the 15q26.1q26.2 deletion interval.

Entities:  

Mesh:

Year:  2009        PMID: 19486360     DOI: 10.1111/j.1528-1167.2009.02078.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  Copy number variants are frequent in genetic generalized epilepsy with intellectual disability.

Authors:  Saul A Mullen; Gemma L Carvill; Susannah Bellows; Marta A Bayly; Holger Trucks; Dennis Lal; Thoman Sander; Samuel F Berkovic; Leanne M Dibbens; Ingrid E Scheffer; Heather C Mefford
Journal:  Neurology       Date:  2013-09-25       Impact factor: 9.910

2.  De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome.

Authors:  Arvid Suls; Johanna A Jaehn; Angela Kecskés; Yvonne Weber; Sarah Weckhuysen; Dana C Craiu; Aleksandra Siekierska; Tania Djémié; Tatiana Afrikanova; Padhraig Gormley; Sarah von Spiczak; Gerhard Kluger; Catrinel M Iliescu; Tiina Talvik; Inga Talvik; Cihan Meral; Hande S Caglayan; Beatriz G Giraldez; José Serratosa; Johannes R Lemke; Dorota Hoffman-Zacharska; Elzbieta Szczepanik; Nina Barisic; Vladimir Komarek; Helle Hjalgrim; Rikke S Møller; Tarja Linnankivi; Petia Dimova; Pasquale Striano; Federico Zara; Carla Marini; Renzo Guerrini; Christel Depienne; Stéphanie Baulac; Gregor Kuhlenbäumer; Alexander D Crawford; Anna-Elina Lehesjoki; Peter A M de Witte; Aarno Palotie; Holger Lerche; Camila V Esguerra; Peter De Jonghe; Ingo Helbig
Journal:  Am J Hum Genet       Date:  2013-10-24       Impact factor: 11.025

Review 3.  Epilepsy and the new cytogenetics.

Authors:  John C Mulley; Heather C Mefford
Journal:  Epilepsia       Date:  2011-01-26       Impact factor: 5.864

4.  CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures.

Authors:  Rhys H Thomas; Lin Mei Zhang; Gemma L Carvill; John S Archer; Sinéad B Heavin; Simone A Mandelstam; Dana Craiu; Samuel F Berkovic; Deepak S Gill; Heather C Mefford; Ingrid E Scheffer
Journal:  Neurology       Date:  2015-02-11       Impact factor: 9.910

5.  Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy.

Authors:  Weixing Feng; Fang Fang; Xiaohui Wang; Chunhong Chen; Junlan Lu; Jie Deng
Journal:  Pediatr Investig       Date:  2022-04-26

Review 6.  Nervous system development and disease: A focus on trithorax related proteins and chromatin remodelers.

Authors:  Amanda Moccia; Donna M Martin
Journal:  Mol Cell Neurosci       Date:  2017-11-28       Impact factor: 4.314

7.  CHD2 variants are a risk factor for photosensitivity in epilepsy.

Authors:  Elizabeth C Galizia; Candace T Myers; Costin Leu; Carolien G F de Kovel; Tatiana Afrikanova; Maria Lorena Cordero-Maldonado; Teresa G Martins; Maxime Jacmin; Suzanne Drury; V Krishna Chinthapalli; Hiltrud Muhle; Manuela Pendziwiat; Thomas Sander; Ann-Kathrin Ruppert; Rikke S Møller; Holger Thiele; Roland Krause; Julian Schubert; Anna-Elina Lehesjoki; Peter Nürnberg; Holger Lerche; Aarno Palotie; Antonietta Coppola; Salvatore Striano; Luigi Del Gaudio; Christopher Boustred; Amy L Schneider; Nicholas Lench; Bosanka Jocic-Jakubi; Athanasios Covanis; Giuseppe Capovilla; Pierangelo Veggiotti; Marta Piccioli; Pasquale Parisi; Laura Cantonetti; Lynette G Sadleir; Saul A Mullen; Samuel F Berkovic; Ulrich Stephani; Ingo Helbig; Alexander D Crawford; Camila V Esguerra; Dorothee G A Kasteleijn-Nolst Trenité; Bobby P C Koeleman; Heather C Mefford; Ingrid E Scheffer; Sanjay M Sisodiya
Journal:  Brain       Date:  2015-03-17       Impact factor: 13.501

8.  Absence epilepsy and the CHD2 gene: an adolescent male with moderate intellectual disability, short-lasting psychoses, and an interstitial deletion in 15q26.1-q26.2.

Authors:  Willem Ma Verhoeven; Jos Im Egger; Alida C Knegt; José Zuydam; Tjitske Kleefstra
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-10       Impact factor: 2.570

9.  Genetic variations and associated pathophysiology in the management of epilepsy.

Authors:  John C Mulley; Leanne M Dibbens
Journal:  Appl Clin Genet       Date:  2011-08-08

Review 10.  Chromatin Remodeling Proteins in Epilepsy: Lessons From CHD2-Associated Epilepsy.

Authors:  Kay-Marie J Lamar; Gemma L Carvill
Journal:  Front Mol Neurosci       Date:  2018-06-15       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.